Glial-driven neuroinflammatory disease model

Glial-driven neuroinflammatory disease model enters the Adult Cognitive Disease corpus through the work of Dan Pulsipher (submission 3), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Dan Pulsipher's submission is summarised in this corpus as:

Alzheimer's disease is not caused by extracellular amyloid plaque or intracellular tau tangles, but rather is a classically activated glial (microglia and astrocyte) and mast cell driven neuroinflammatory disease in which TNF-alpha and other pro-inflammatory cytokines play central roles. TNF-alpha inhibitors such as Infliximab, administered intrathecally, represent a promising treatment approach, along with PK11195 SPECT neuroimaging to identify activated microglia.

Where it sits

The submission scores against the framework's convergence nodes as: neuroimmune interface 9 · compensatory paradigm 3.

Its declared subject matter: neuroinflammation, TNF-alpha, microglia, astrocytes, mast cells, Infliximab, anti-inflammatory therapy.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: Activated microglia imaging for treatment guidance · Anti-TNF-alpha therapeutic strategy · TNF-alpha as central AD mediator.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.